Systemic Inflammation and Lung Function Impairment in Morbidly Obese Subjects with the Metabolic Syndrome
Table 1
General characteristics of the population included in the study.
No metabolic syndrome ()
Metabolic syndrome ()
value
Age (years)
37 ± 11
43 ± 10
<0.0011
BMI (kg/m2)
45.4 ± 6.7
46.0 ± 6.5
0.395
Gender (% female)
87.4%
73.7%
0.0012
Ethnicity (% Caucasian)
80.5%
85.0%
0.222
Smoking
0.152
% never smoked
49%
40%
% stopped smoking
29%
32%
% smokes
22%
28%
Pack years3
6.0 ± 11.2
9.9 ± 14.8
0.003
Abdominal circumference (cm)
126.8 ± 14
134.3 ± 16
<0.001
Systolic blood pressure (mm Hg)
136.4 ± 17.9
145.98 ± 16.6
<0.001
Diastolic blood pressure (mm Hg)
83.6 ± 11.8
87.83 ± 10.1
<0.001
Comorbidities
Diabetes mellitus
3.8%
30.3%
<0.001
Hypertension
18.9%
42.8%
<0.001
Hypercholesterolemia
1.9%
21.7%
<0.001
Self-reported asthma
19.6%
21.0%
0.723
Use of inhaled corticosteroids
3.8%
5.5%
0.413
1Data presented as mean ± standard deviation, value for Student’s test,
2Data presented as percentage, value for Chi-square test.
3Data were log transformed for statistical analysis.
